Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases.]
Central and peripheral demyelination.
Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4.
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
In vivo histology of the myelin g-ratio with magnetic resonance imaging.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies.
Vitamin D as a clinical biomarker in multiple sclerosis.
MS as a gateway disease.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
Few patients with neurodegenerative disorders require spinal surgery.
Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
Driving performance in persons with mild to moderate symptoms of multiple sclerosis.
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
Goal attainment in cognitive rehabilitation in MS patients.
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
Improving the quality of mental health care in Multiple Sclerosis.
The Effect of a Creative Art Program on Self-Esteem, Hope, Perceived Social Support, and Self-Efficacy in Individuals With Multiple Sclerosis: A Pilot Study.
Targeting IL-10 in Auto-immune Diseases.
Coenzyme Q10 Supplementation Reduces Oxidative Stress and Increases Antioxidant Enzyme Activity in Patients with Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
337
338
339
340
341
342
343
344
345
…
next ›
last »